Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BYJAAD international

Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study

  • Ahmad Alsarraf1
  • Hashem Boalbanat1
  • Jihan Rajy2
  • Karen Pinto3
  • Dina Elkady3
  • Rasha Abdel Tawab Hamed3
  1. 1Kuwait Institute of Medical Specialization, Kuwait City, Kuwait
  2. 2As’ad Al-Hamad Dermatology Center, Kuwait City, Kuwait
  3. 3Kuwait Cancer Control Center, Kuwait City, Kuwait
Read full textPDFCite

Related

  1. Expert consensus on the management of peripheral neuropathy in patients with lymphoma on brentuximab vedotin.
    Roser Velasco, José A Sanches, Andreas A Argyriou +13
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BYFull textOncologyEurope PMC
  2. Routine Clinical Nemolizumab Use Before or After Cutaneous T-Cell Lymphoma Diagnosis
    Krithika Nayudu, Chirag Vasavda, Farrah Buckhoree +6
    JAMA DermatologyPeer-reviewedLicence not statedFull textGeneral medicinePMC
  3. Clonal expansion of CAR-T cells harboring lentivector integration in the PLAAT4 gene following anti-CD19 CAR T-cell therapy in a context of cutaneous T-cell lymphoma
    Vincent Guiraud, Clotilde Bravetti, Amélie Guihot +13
    HaematologicaPeer-reviewedCC BY-NC 4.0Full textImmunologyOncologyHAL
  4. Cutaneous T-Cell Lymphoma and Cutaneous CAR-T Lymphoma in Patients with Other Malignancies
    Caroline S. Myers, Elise A. Olsen, Christina Cruz +4
    CancersPeer-reviewedCC BY 4.0OncologyCrossref
  5. Follicular Lymphoma Involving the Supraglottic Larynx in a Patient with Recurrent Cutaneous B-cell Lymphoproliferative Lesions: A Case Report
    Ryohei Asai, Hiroumi Matsuzaki, Shimon Otake +2
    Internal MedicinePeer-reviewedCC BY-NC-NDFull textGeneral medicineJ-STAGE

Cite

BibTeXRIS
BibTeX
@article{alsarraf2026outcomes,
  title = {{Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study}},
  author = {Ahmad Alsarraf and Hashem Boalbanat and Jihan Rajy and Karen Pinto and Dina Elkady and Rasha Abdel Tawab Hamed},
  journal = {JAAD international},
  year = {2026},
  month = aug,
  url = {https://europepmc.org/article/PMC/PMC13652849},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Outcomes of brentuximab vedotin in cutaneous T-cell lymphoma: A Middle Eastern real-world study
AU  - Ahmad Alsarraf
AU  - Hashem Boalbanat
AU  - Jihan Rajy
AU  - Karen Pinto
AU  - Dina Elkady
AU  - Rasha Abdel Tawab Hamed
PY  - 2026
DA  - 2026/08/14
JO  - JAAD international
UR  - https://europepmc.org/article/PMC/PMC13652849
SN  - 2666-3287
ER  -